Drug
Beclomethasone Dipropionate For Nebulization
Beclomethasone Dipropionate For Nebulization: highest development phase Phase 3, developed by Chiesi Farmaceutici. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| beclomethasone dipropionate 800 mcg/2 ml suspension for nebulization,one administration b.i.d. for 14 days NCT01691677 | Phase 3 | Acute Rhinosinusitis |
Latest
No recent events.
Follow Beclomethasone Dipropionate For Nebulization on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.